Last updated: 9 August 2024 at 4:40pm EST

Dr. Kenneth E. Johnson Pharm. D., Pharm.D. Net Worth




The estimated Net Worth of Kenneth Erland Johnson is at least $17.5 Mille dollars as of 14 February 2020. Dr Johnson owns over 2,410 units of Xeris Biopharma Inc stock worth over $17,489 and over the last 6 years he sold XERS stock worth over $0.

Dr D XERS stock SEC Form 4 insiders trading

Dr has made over 2 trades of the Xeris Biopharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 2,410 units of XERS stock worth $10,002 on 14 February 2020.

The largest trade he's ever made was buying 2,410 units of Xeris Biopharma Inc stock on 14 February 2020 worth over $10,002. On average, Dr trades about 213 units every 23 days since 2018. As of 14 February 2020 he still owns at least 6,115 units of Xeris Biopharma Inc stock.

You can see the complete history of Dr Johnson stock trades at the bottom of the page.





Dr. Kenneth E. Johnson Pharm. D., Pharm.D. biography

Dr. Kenneth E. Johnson Pharm. D., Pharm.D. is the Sr. VP of Clinical Devel., Regulatory, Quality Assurance & Medical Affairs at Xeris Biopharma Inc.



How old is Dr D?

Dr D is 58, he's been the Sr. VP of Clinical Devel., Regulatory e Quality Assurance & Medical Affairs of Xeris Biopharma Inc since . There are 7 older and 11 younger executives at Xeris Biopharma Inc. The oldest executive at Xeris Biopharma Holdings Inc is Jeffrey Sherman, 65, who is the Independent Director.

What's Dr D's mailing address?

Kenneth's mailing address filed with the SEC is C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607.

Insiders trading at Xeris Biopharma Inc

Over the last 6 years, insiders at Xeris Biopharma Inc have traded over $2,845,230 worth of Xeris Biopharma Inc stock and bought 2,912,235 units worth $31,442,123 . The most active insiders traders include Group, Llc Green Jeremy Red..., James E Deerfield Mgmt L.P.... e Garheng Kong. On average, Xeris Biopharma Inc executives and independent directors trade stock every 46 days with the average trade being worth of $197,048. The most recent stock trade was executed by John P. Schmid on 12 August 2024, trading 4,515 units of XERS stock currently worth $10,159.



What does Xeris Biopharma Inc do?

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.



What does Xeris Biopharma Inc's logo look like?

Xeris Biopharma Holdings Inc logo

Complete history of Dr Johnson stock trades at Xeris Biopharma Inc

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
14 Feb 2020 Kenneth Erland Johnson
See Remarks
Acquistare 2,410 $4.15 $10,002
14 Feb 2020
6,115
19 Feb 2019 Kenneth Erland Johnson
See Remarks
Acquistare 1,000 $10.00 $10,000
19 Feb 2019
3,245


Xeris Biopharma Inc executives and stock owners

Xeris Biopharma Inc executives and other stock owners filed with the SEC include: